Aarvik Therapeutics and ArriVent Biopharma Announce Research Collaboration to Advance Novel Oncology Drug Candidate Using Aarvik’s Proprietary Modular Antibody Platform

FREMONT, Calif. & NEWTOWN SQUARE, Pa.--(BUSINESS WIRE)-- #biotechnology--Aarvik Therapeutics and ArriVent Biopharma announce a strategic research collaboration to develop and commercialize a novel oncology drug candidate.

Click to view original post